Apex Research Institute

Santa Ana, California 92705

0 studies enrolling now · 31 studies all time

What they study most

Alzheimer's Disease, Arthritis, Attention Deficit Hyperactivity Disorder, Chronic Heart Failure, Congestive Heart Failure, Diabetic Neuropathy, Painful, Early Alzheimer's Disease, Fibromyalgia, Healthy Normal Volunteers, Hot Flashes, Hypertension, Insomnia

Studies at this site

• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease — Completed
• Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System — Completed
• A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
• Adolescent Fibromyalgia Study — Completed
• Pregabalin In Adolescent Patients With Fibromyalgia — Completed
• Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients — Completed
• Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant — Completed
• Evaluation of Cilostazol in Combination With L-Carnitine — Completed
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication — Completed
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms — Completed
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure — Completed
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
• Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease — Completed
• Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed
• Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure. — Completed
• Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker — Completed
• A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia — Completed
• A Normal Donor Sample Collection Study in Healthy Adults — Completed
• Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia — Completed
• Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246 — Completed
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator — Completed
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients — Status unconfirmed